Intrinsic Value of S&P & Nasdaq Contact Us

Elevation Oncology, Inc. ELEV NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
41/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$9.00
+2365.8%

Elevation Oncology, Inc. (ELEV) has 6 identified peers for comparison in the Healthcare sector. Peers include AVRO, CWBR, ENVB, HEPA, OCEA, ZURA.

ELEV has a market capitalization of $21.63M, compared to an average peer market cap of $63.38M. ELEV is notably smaller than its average peer.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message